Related Experiment Video

Updated: Oct 22, 2025

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.4K

Prognosis of MAFLD vs. NAFLD and implications for a nomenclature change

Vincent Wai-Sun Wong1, Jeffrey V Lazarus2

  • 1Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong.

Journal of Hepatology
|August 31, 2021
PubMed
Abstract

No abstract available in PubMed .

Keywords:
MAFLDNAFLDNASHmetabolic dysfunction-associated fatty liver diseasenon-alcoholic fatty liver diseasenon-alcoholic steatohepatitis

More Related Videos

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

12.2K
Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

1.1K

Related Experiment Videos

Last Updated: Oct 22, 2025

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.4K
Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

12.2K
Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

1.1K

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

238
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
238
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

74
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
74

Articles linked to this work by shared authors, journal, and citation graph.

Metabolic dysfunction-associated steatotic liver disease in people living with HIV: a framework for integrated screening and care.

The lancet. HIV·2026

Steatotic liver disease trajectory: A holistic EASL guidance on the multidisciplinary approach to screening and patient management.

JHEP reports : innovation in hepatology·2026

Metabolic Dysfunction-associated Steatotic Liver Disease in Romania: A Multidisciplinary Position Paper on Prevalence, Clinical Spectrum, Prevention, Screening and Management.

Journal of gastrointestinal and liver diseases : JGLD·2026

Frailty may confound the association between MASLD and cardiovascular mortality in people with cardiometabolic risk factors.

Cardiovascular diabetology·2026

Addressing the Public Health Threat of Steatotic Liver Disease in Mexico.

Archives of medical research·2026

Global trends in national alcohol control policies between 2010 and 2019.

JHEP reports : innovation in hepatology·2026

Mouse models of acute and chronic hepatitis E virus infection.

Journal of hepatology·2026

Barriers to Viral Hepatitis Elimination and New Strategies to Overcome Them in Low- and Middle-Income Countries.

Journal of hepatology·2026

Emerging strategies for hepatocellular carcinoma surveillance: abbreviated MRI, biomarkers and benefit stratification.

Journal of hepatology·2026

Artificial intelligence and personalised medicine in liver cancer.

Journal of hepatology·2026

Spleen stiffness measurement rules out high-risk varices in patients with chronic portal vein thrombosis without cirrhosis.

Journal of hepatology·2026

Serum HBsAg cannot distinguish cccDNA activity from integrated HBV DNA expression in chronic hepatitis B virus infection.

Journal of hepatology·2026

What do we know about medical invalidation and related concepts? - A scoping review and thematic analysis about the definitions, measurements, causes, consequences and potential solutions for medical invalidation.

BMC health services research·2026

Implant migration and clinical outcomes with cemented vs cementless Motec cups in total trapeziometacarpal arthroplasty: a 10-year prospective RSA cohort study of 69 patients.

Acta orthopaedica·2026

ExchangeXplorer: an R/Shiny application for processing and visualization of LC-HDX-MS data in metabolomics, lipidomics, and exposomics.

Analytica chimica acta·2026

Diagnostic and prognostic value of fibroblast growth factor 23 in acute kidney injury: systematic review and meta-analysis.

Renal failure·2026

TIMS-MS combined with theoretical modeling for flavonoid isomer separation using cyclodextrin-metal ion ternary complexes.

Food chemistry·2026

In men with osteoporosis/osteopenia, denosumab, alendronate, and zoledronic acid did not differ for lumbar spine BMD at 12 mo.

Annals of internal medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us